Last reviewed · How we verify
NCT06032481
System to Evaluate the Risk of Lymph Node Metastasis Preoperatively in Cervical Cancer
trial testing surgery in Cervical Cancer in 426 participants. Completed in 15 March 2023.
1 December 2019
Quick facts
| Lead sponsor | Fujian Maternity and Child Health Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 426 |
| Start date | 1 January 2012 |
| Primary completion | 1 December 2019 |
| Estimated completion | 15 March 2023 |
Drugs / interventions tested
- surgery
Conditions studied
- Cervical Cancer — all drugs for Cervical Cancer →
Sponsor
Fujian Maternity and Child Health Hospital
Who can join
Adults 25 to 70, female only, with Cervical Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The lymph node status is difficult to be assessed preoperatively, this study aimed to develop a scoring system for predicting the risk of LNM in cervical cancer patients before operation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06032481
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of surgery
Trials testing the same drug.
- NCT07135336 — Incidence of Postoperative Cognitive Decline in Patients With Preexisting Cognitive Impairment · recruiting
- NCT06912711 — TN Induction and Adjuvant Therapy for Resectable Local Recurrent Nasopharyngeal Carcinoma · Phase 2 · recruiting
- NCT06944470 — JS207 Combined With Chemotherapy in Subjects With Stage II-III NSCLC · Phase 2 · not yet recruiting
- NCT06915909 — Robotic Prostatectomy Artificial Intelligence Low Pressure Pain (RALP) Trial · NA · not yet recruiting
- NCT06751394 — Preoperative Chemoradiotherapy and Toripalimab in Locally Recurrent Rectal Cancer · Phase 2 · not yet recruiting
Other recruiting trials for Cervical Cancer
Currently open trials in the same condition.
- NCT07276360 — Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda · Phase 2 · recruiting
- NCT05570422 — A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01 · Phase 1 · recruiting
- NCT07225530 — Implementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR) · NA · recruiting
- NCT07209917 — Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India · NA · recruiting
- NCT07256236 — SKB264 Plus QL1706 in Recurrent or Metastatic Cervical Cancer · Phase 2 · recruiting
Other Fujian Maternity and Child Health Hospital trials
Trials by the same sponsor.
- NCT06276309 — Protein Molecular Characteristics and Prognosis of Cervical Neuroendocrine Tumors · recruiting
- NCT06137352 — Two Domestic HPV Vaccines and Imported HPV Vaccines in Women Aged 13-14 Years Study on Immunogenicity · not yet recruiting
- NCT06204133 — Model Study on Cervical Cancer Screening Strategies and Risk Prediction · completed
- NCT05932563 — Study on the Epidemiological Characteristics of Female HPV Vaccination in China · unknown
- NCT05745597 — Prognostic Study of HPV Virus Integration in Women With HSIL · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06032481 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fujian Maternity and Child Health Hospital
- Last refreshed: 13 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06032481.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing